(1)
Lazzaro, C.; Mazzanti, N. A.; Parazzini, F. Severe Haematological Toxicities in Relapsed Ovarian Cancer Treated With Olaparib or Niraparib: An Italian Cost-Minimization Analysis. Grhta 2019, 6.